Sections
Shows
Events
Covaxin phase 3 trial data released: Jab shows 65.2% efficacy against Delta COVID-19 variant, says company
As India preps for COVID-19 vaccine rollout, Centre says 'no proposal' to indemnify vaccine manufacturers
Harsh Vardhan hails clearance for COVID-19 vaccines as 'watershed moment'; Congress questions 'premature' nod to COVAXIN
